Summary of Study ST003238
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002013. The data can be accessed directly via it's Project DOI: 10.21228/M8DJ7S This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003238 |
Study Title | Lipidomic analysis of serum from Gclc WT and whole-body Gclc KO mice. |
Study Summary | We found decreased triglycerides in the serum of whole-body deletion of Gclc mice compared to wildtype mice. |
Institute | University of Rochester Medical Center |
Last Name | Harris |
First Name | Isaac |
Address | 601 Elmwood Ave, Rochester, New York, 14642-0001, USA |
isaac_harris@urmc.rochester.edu | |
Phone | 8572348624 |
Submit Date | 2024-05-29 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2024-06-07 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR003366 |
Treatment Summary: | Gclc WT (Gclc f/f) and whole-body Gclc KO (Gclc f/f Rosa26-CreERT2) were treated with 160 mg/kg i.p. injection of tamoxifen daily for five consecutive days. After approximately 14 days, mice were euthanized and serum was isolated and stored. |